BAX — what changed in the latest 10-Q
A section-by-section comparison of BAX's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-10-29 vs the prior 10-Q · 2026-07-30
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +54 | −51 | ~44 | 47 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~5 | 2 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Other information | No paragraph-level changes | 0 | 0 | 0 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-10-29
operating room integration technologies, precision positioning devices, and other accessories.
Total Healthcare Systems & Technologies net sales$2,312 $2,244 3 %2 %
Care & Connectivity Solutions net sales increased 5% in the third quarter and increased 4% in the first nine months of 2026, as compared to the prior year periods. The increase in the third quarter was primarily driven by acceleration of our global surgical solutions business and increased volume as…
Three Months Ended September 30,Nine Months Ended September 30,
Impact on Effective Tax Rate10.2 pts137.0 pts8.0 pts33.3 pts
Text removed vs the prior filing · source: 10-Q · 2026-07-30
Total Healthcare Systems & Technologies net sales$801 $767 4 %4 %
Care & Connectivity Solutions net sales increased 6% in the second quarter and increased 4% in the first six months of 2026, as compared to the prior year periods. Sales performance was primarily driven by increased volume associated with execution against the order backlog in the U.S. for patient s…
Impact on Effective Tax Rate(5.3)pts(8.4)pts3.1 pts(60.1)pts
1Our results for the second quarter of 2026 and 2025 included business optimization charges of $7 million and $17 million, respectively. Our results for the first six months of 2026 and 2025 included business optimization charges of $75 million and $62 million, respectively. These restructuring and …
2Our results for the second quarter of 2026 and 2025 included $4 million and $5 million, respectively, and for the first six months of 2026 and 2025 included $8 million and $10 million, respectively, of incremental costs to comply with the European Union's medical device regulations for previously r…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice